These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26460076)

  • 21. Association of Lp-PLA(2) activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome.
    Chae JS; Kim OY; Paik JK; Kang R; Seo WJ; Jeong TS; Sweeney G; Lee SH; Lee JH
    Atherosclerosis; 2011 Oct; 218(2):499-506. PubMed ID: 21762913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice.
    Zhang H; Zhang J; Shen D; Zhang L; He F; Dang Y; Li L
    Int J Mol Med; 2013 Mar; 31(3):651-9. PubMed ID: 23338278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
    Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
    Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein-associated phospholipase A(2): a promising vascular-specific marker for screening cardiovascular risk?
    Lee JH; Engler MM
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):181-9. PubMed ID: 20002343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the Gln223Arg polymorphism of the leptin receptor and metabolic syndrome in free-living community elderly.
    Gottlieb MG; Bodanese LC; Leite LE; Schwanke CH; Piccoli Jda C; da Rocha MI; da Cruz IB
    Metab Syndr Relat Disord; 2009 Aug; 7(4):341-8. PubMed ID: 19344216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Darapladib and atherosclerotic plaque: should lipoprotein-associated phospholipase A2 be a therapeutic target?
    McCullough PA
    Curr Atheroscler Rep; 2009 Sep; 11(5):334-7. PubMed ID: 19664375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2.
    Fenning RS; Burgert ME; Hamamdzic D; Peyster EG; Mohler ER; Kangovi S; Jucker BM; Lenhard SC; Macphee CH; Wilensky RL
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25672369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.
    Agouridis AP; Tsimihodimos V; Filippatos TD; Dimitriou AA; Tellis CC; Elisaf MS; Mikhailidis DP; Tselepis AD
    Expert Opin Pharmacother; 2011 Dec; 12(17):2605-11. PubMed ID: 21714585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population.
    Zhang SY; Shibata H; Karino K; Wang BY; Kobayashi S; Masuda J; Nabika T
    Hypertens Res; 2007 May; 30(5):403-9. PubMed ID: 17587752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipoprotein associated phospholipase A2].
    Rubinstein A; Izkhakov E
    Harefuah; 2011 Feb; 150(2):136-40, 205. PubMed ID: 22164942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal waist circumference and the prediction of children's metabolic syndrome.
    Hirschler V; Roque MI; Calcagno ML; Gonzalez C; Aranda C
    Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children.
    Chen XY; Zhang JH; Liu F; Liu HM; Song YY; Liu YL
    J Pediatr Endocrinol Metab; 2013; 26(9-10):855-60. PubMed ID: 23729554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases.
    Theocharidou E; Tellis CC; Mavroudi M; Soufleris K; Gossios TD; Giouleme O; Athyros VG; Tselepis AD; Karagiannis A
    J Crohns Colitis; 2014 Sep; 8(9):936-44. PubMed ID: 24529818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
    Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
    Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis.
    Badellino KO; Wolfe ML; Reilly MP; Rader DJ
    PLoS Med; 2006 Feb; 3(2):e22. PubMed ID: 16354105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children.
    Mauras N; Delgiorno C; Kollman C; Bird K; Morgan M; Sweeten S; Balagopal P; Damaso L
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1060-8. PubMed ID: 20061420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients.
    Rosing K; Fobker M; Kannenberg F; Gunia S; Dell'Aquila AM; Kwiecien R; Stypmann J; Nofer JR
    Atherosclerosis; 2013 Sep; 230(1):164-70. PubMed ID: 23958269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.